Power Diary Announces End of Year Offer
Power Diary, a leading practice management software for allied healthcare practitioners, is thrilled to roll out an exclusive, limited-time offer to help new subscribers finish the year strong.
Companies in the News
Health & Pharm General
Everybody Clinics Broadbeach Now Open, Offering Non-Invasive Cryolipolysis Treatments
Everybody Clinics Broadbeach Now Open, Offering Non-Invasive Cryolipolysis Treatments Everybody Clinics is excited to announce the opening of their newest location in Broadbeach, offering non-invasive cryolipolysis treatments.
Proteomics International Laboratories Ltd (ASX:PIQ) AGM Chairman's Address and Investor Presentation
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the Chairman's Address provided by Mr Neville Gardiner and the Investor Presentation provided by Dr Richard Lipscombe to shareholders.
MEMPHIS BECOMES A SAFETY NET FOR MUSICIANS WORLDWIDE
Memphis, TN - Road to Memphis International Song Contest is excited to announce the release of its comprehensive impact report for 2023, showcasing the remarkable positive outcomes experienced by participants through the provision of free life coaching and psychological support.
Everybody Clinics Revolutionary Non-Surgical Technology Offers Safe and Effective Fat Removal Alternative
Everybody Clinics Revolutionary Non-Surgical Technology Offers Safe and Effective Fat Removal Alternative. Say goodbye to stubborn fat pockets with the latest non-surgical technology from Everybody Clinics.
VET Resources Revolutionises Learning with the Launch of Innovative E-Learning SCORM Package
VET Resources, a trailblazer in the field of vocational education and training, proudly unveils its latest achievement: the groundbreaking E-Learning SCORM Package.
Proteomics International Laboratories Ltd (ASX:PIQ) US Medicare Confirms Reimbursement Price for PromarkerD
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that the US Centers for Medicare & Medicaid Services has published its final determination of the national reimbursement price in the United States for the PromarkerD predictive test for diabetic kidney disease.
◂Previous Page
Health & Pharm General Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
Social Media
